[Abnormal hepatic copper accumulation and its significance in LEC rats developing spontaneous hepatitis and hepatoma].
The LEC rat is a mutant inbred strain isolated from Long-Evans rats, which spontaneously develops hepatitis and hepatoma with high frequency. In this study, copper profiles of LEC rats, including copper concentration in the liver and concentrations of copper and ceruloplasmin in the serum, were investigated. It was found that copper accumulated in the liver of LEC rats immediately prior to the onset of hepatitis with a concentration of more than 50 times that of normal LEA rats, and serum concentrations of copper and ceruloplasmin decreased markedly, which resembled biochemically characteristic features of human Wilson's disease. Administration of d-penicillamine (100 mg/Kg/day p. o), a chelating agent, reduced the hepatic copper level and completely inhibited the development of hepatitis in LEC rats. Copper also accumulated in both cancerous and non-cancerous liver tissues of three 29-month old male LEC rats which had spontaneously developed hepatocellular carcinomas. These findings suggest that the hepatitis in LEC rats is caused by copper toxicity, and that the abnormal copper metabolism may be involved in hepatic carcinogenesis in the LEC rats. Therefore, it is considered that the LEC rat will provide a promising animal model for not only elucidating the pathogenesis of Wilson's disease and developing treatment strategies of the disease, but also for studying the role of copper in hepatic carcinogenesis.
Li
Y
Y
First Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D002570:Ceruloplasmin / Q000378:metabolism; D003300:Copper / Q000378:metabolism*; D004195:Disease Models, Animal; D005260:Female; D006520:Hepatitis, Animal / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D006527:Hepatolenticular Degeneration / Q000378:metabolism* / Q000517:prevention & control; D008099:Liver / Q000378:metabolism*; D008114:Liver Neoplasms, Experimental / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D008297:Male; D010396:Penicillamine / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D011922:Rats, Mutant Strains
D003300:Copper; D002570:Ceruloplasmin; D000410:Alanine Transaminase; D010396:Penicillamine